Dr. Özlem Türeci revolutionized global healthcare through her groundbreaking work in messenger RNA technology. As co-founder of BioNTech, she led the development of the first approved COVID-19 vaccine, transforming pandemic response worldwide.

Since 2018, she has served as the company's chief medical officer, leveraging her deep expertise in personalized immunotherapy. Her scientific journey blends medical innovation with entrepreneurial vision, demonstrating how targeted research can create life-saving medical solutions. Since 2021, Türeci has also been a Professor of Personalized Immunotherapy at the Helmholtz Institute, continuing to push the boundaries of cancer research and immune system treatments.

Her keynotes offer profound insights into medical innovation, biotechnology breakthroughs, and the future of precision medicine.